EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research on the role and mechanism of IL-17 in intervertebral disc degeneration

Bing Peng, Qian Li, Jiangping Chen, Zhexiang Wang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.111992 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Bing Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Liuyang Hospital of Traditional Chinese Medicine, Liuyang City, Hunan Province, China; Tianjin University of Traditional Chinese Medicine, Tianjin, C…. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Interleukin-17. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 166 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intervertebral disc degeneration (IDD) is one of the primary causes of low back pain (LBP), which seriously affects patients' quality of life. In recent years, interleukin (IL)-17 has been shown to be highly expressed in the intervertebral disc (IVD) tissues and serum of patients with IDD, and IL-17A has been shown to promote IDD through multiple pathways. We first searched databases such as PubMed, Cochrane, Embase, and Web of Science using the search terms "IL-17 or interleukin 17″ and "intervertebral discs". The search period ranged from the inception of the databases to December 2023. A total of 24 articles were selected after full-text screening. The main conclusion of the clinical studies was that IL-17A levels are significantly increased in the IVD tissues and serum of IDD patients. The results from the in vitro studies indicated that IL-17A can activate signaling pathways such as the NF-κB and MAPK pathways; promote inflammatory responses, extracellular matrix degradation, and angiogenesis; and inhibit autophagy in nucleus pulposus cells. The main finding of the in vivo experiments was that puncture of animal IVDs resulted in elevated levels of IL-17A within the IVD, thereby inducing IDD. Clinical studies, in vitro experiments, and in vivo experiments confirmed that IL-17A is closely related to IDD. Therefore, drugs that target IL-17A may be novel treatments for IDD, providing a new theoretical basis for IDD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intervertebral Disc DegenerationInterleukin-17HumansAnimalsIntervertebral DiscSignal TransductionNucleus PulposusLow Back Pain

Stichwörter der Autor:innen

Interleukin 17Intervertebral disc degenerationPathological mechanisms

Substanzen

Interleukin-17IL17A protein, human

Autor:innen und Institutionen

  • Liuyang Hospital of Traditional Chinese Medicine, Liuyang City, Hunan Province, China; Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Liuyang Hospital of Traditional Chinese Medicine, Liuyang City, Hunan Province, China.
  • Hunan Provincial Hospital of Integrative Traditional Chinese and Western Medicine, Changsha City, Hunan Province, China. Electronic address: wangzhexiangdoctor@163.com.

Zitieren

APA

Peng, B., Li, Q., Chen, J., & Wang, Z. (2024). Research on the role and mechanism of IL-17 in intervertebral disc degeneration. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.111992

Vancouver

Peng B, Li Q, Chen J, Wang Z. Research on the role and mechanism of IL-17 in intervertebral disc degeneration. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.111992

BibTeX
@article{Peng2024,
  author = {Peng, Bing and Li, Qian and Chen, Jiangping and Wang, Zhexiang},
  title = {Research on the role and mechanism of IL-17 in intervertebral disc degeneration},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.111992}
}
Kostenlos starten →